These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 94289)

  • 1. [Reactions provoked by maternal fetal interchanges. Their application to prenatal sex determination].
    Ruíz-Castañeda M
    Gac Med Mex; 1979 Nov; 115(11):497-500. PubMed ID: 94289
    [No Abstract]   [Full Text] [Related]  

  • 2. Current techniques of prenatal screening for Down syndrome.
    Cardwell MS; Gay JW
    Mo Med; 1990 May; 87(5):295-7. PubMed ID: 1694954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Does systemic determination of maternal serum alpha-1-fetoprotein have any value?].
    Muller F; Pantin G; Normand N; Bucheton D; Der Sarkissian H; Boué J; Giraudet P; Henrion R; Boué A
    Arch Fr Pediatr; 1990; 47(6):473-4. PubMed ID: 1698351
    [No Abstract]   [Full Text] [Related]  

  • 4. 46,XY,i(21q) identified by maternal serum screening.
    Meyers CM; Ghori S; Roberson AE; Blitzer MG; Cohen MM
    Md Med J; 1997 Feb; 46(2):88-9. PubMed ID: 9029908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual analyte screening for fetal Down syndrome in pregnant women over 35 years of age.
    Cavalli P; Gnocchi E; Pennacchio A; Morrica B
    Prenat Diagn; 1998 Jun; 18(6):637-8. PubMed ID: 9664616
    [No Abstract]   [Full Text] [Related]  

  • 6. Maternal serum screening for fetal Down syndrome in IVF pregnancies.
    Ribbert LS; Kornman LH; De Wolf BT; Simons AH; Jansen CA; Beekhuis JR; Mantingh A
    Prenat Diagn; 1996 Jan; 16(1):35-8. PubMed ID: 8821850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of maternal serum screening programs for Down syndrome in southeast Michigan, 1988-2003.
    Van Dyke DL; Ebrahim SA; Al Saadi AA; Powell SA; Zenger-Hain JL; Micale MA; Wiktor AE; Zou YS
    Prenat Diagn; 2007 Jun; 27(6):583-4. PubMed ID: 17546696
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical uses of maternal serum markers in the prenatal diagnosis].
    Li G; Huang X
    Zhonghua Fu Chan Ke Za Zhi; 1998 Apr; 33(4):252-4. PubMed ID: 10682475
    [No Abstract]   [Full Text] [Related]  

  • 9. Prenatal screening for open neural tube defects, Down's syndrome, and other major fetal disorders.
    Haddow JE
    Semin Perinatol; 1990 Dec; 14(6):488-503. PubMed ID: 1706536
    [No Abstract]   [Full Text] [Related]  

  • 10. Prenatal diagnosis.
    Ferguson-Smith MA
    Practitioner; 1974 Nov; 213(1277):655-66. PubMed ID: 4142084
    [No Abstract]   [Full Text] [Related]  

  • 11. [The prenatal diagnosis of Down's syndrome based on the biochemical screening of maternal serum markers].
    Arbuzova SB; Nikolenko MI; Khlevnaia LA; Fedotova OO; Solov'eva VD; Malova SA
    Tsitol Genet; 1998; 32(1):66-71. PubMed ID: 9695254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Screening for alpha-1-fetoprotein in maternal serum. Clinical and organizational aspects in the Central Bohemia Region].
    Stejskal D; Malbohan I
    Cesk Gynekol; 1988 Aug; 53(7):538-43. PubMed ID: 2458848
    [No Abstract]   [Full Text] [Related]  

  • 13. [Prenatal screening for Down syndrome: from sequential to combined estimated risk].
    Jouannic JM; Benifla JL
    Gynecol Obstet Fertil; 2006 Jun; 34(6):467-9. PubMed ID: 16716636
    [No Abstract]   [Full Text] [Related]  

  • 14. [Determination of alpha fetoprotein in prevention and diagnosis].
    Fuhrmann W
    Gynakologe; 1988 Jun; 21(2):125-9. PubMed ID: 2456970
    [No Abstract]   [Full Text] [Related]  

  • 15. Prenatal cytogenetic screening.
    Simpson JL
    Ultrasound Obstet Gynecol; 1995 Jan; 5(1):3-5. PubMed ID: 7531607
    [No Abstract]   [Full Text] [Related]  

  • 16. [AFP, uE3, beta-hCG levels applied for prenatal diagnosis of Down's syndrome].
    Liao S; Wang Y; Ye G
    Zhonghua Fu Chan Ke Za Zhi; 1997 Nov; 32(11):655-8. PubMed ID: 9639764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of combining maternal serum alpha-fetoprotein and hCG in a second-trimester screening program for Down syndrome.
    Mooney RA; Peterson CJ; French CA; Saller DN; Arvan DA
    Obstet Gynecol; 1994 Aug; 84(2):298-303. PubMed ID: 7518896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Second-trimester maternal serum screening for Down syndrome in Mainland China.
    Liao C; Huang Y; Li D; Song S; Yi C; Zhou J
    Prenat Diagn; 2006 Dec; 26(13):1271-2. PubMed ID: 17139699
    [No Abstract]   [Full Text] [Related]  

  • 19. [Alpha-fetoprotein and trisomy 21].
    Guibaud S; Boisson C; Simplot A; Thoulon JM; Favier JP; Guibaud P; Robert JM
    J Genet Hum; 1988 Aug; 36(4):347-51. PubMed ID: 2464665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Significance of pathological alpha-1-fetoprotein levels in the framework of prenatal diagnosis].
    Casper F; Möbus V; Wellek S; Gehm D; Seufert R; Brockerhoff P; Kreienberg R
    Z Geburtshilfe Perinatol; 1992; 196(1):7-10. PubMed ID: 1372459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.